A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Metformin (Primary) ; Ritonavir (Primary)
- Indications Chronic lymphocytic leukaemia; Multiple myeloma
- Focus Adverse reactions
- 22 Mar 2018 Planned End Date changed from 1 Sep 2018 to 1 Oct 2018.
- 22 Mar 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Oct 2018.
- 22 Mar 2018 Status changed from recruiting to active, no longer recruiting.